- 2024.08.08Announcement about survey for physicians' survey database "PatientsMap" US version to be conducted
- 2024.02.29Rare Disease Day 2024
--- Focusing on treatment gaps in rare diseases --- - 2023.09.07Analysis of the potential for administering new drugs in terms of the number of patients
- from PatientsMap2022JP version - - 2023.07.21Analysis of the potential for administering new drugs in terms of the number of patients
- from PatientsMap2022JP version - - 2023.02.02PatientsMap 2022 US version now available
- 2022.11.11PatientsMap 2022 Japan version now available
- 2022.08.25Analysis by scale of hospitals and cities by the top 10 companies in China in terms of sales rep activities (6 foreign-funded and 4 domestic-funded).
- 2022.06.28PatientsMap 2022 Japan Survey Begins.
- 2022.06.09PatientsMap analysis of Chinese physicians’ needs for new drugs
- 2022.04.22Launch of PatientsMap China 2022
- 2020.12.14Final Results of Cyberattack Incident Investigation
- 2020.09.02PatientsMap database is now available in English. Try out the demo version!
- 2016.05.06CI Insight Report "Research of China’s COPD Market"
- 2016.02.10Medical conditions with new product needs: A comparison of US vs. Japan through a large-scale physician survey (PatientsMap) Click here to see the full press release (PDF)
- 2015.08.21SSRI CHINA completes its investment in HIMA, a Shanghai-based pharmaceutical market research company. Click here to see the full press research (PDF)
